QAMZOVA
LIVE

Serial Number

99060475

Owner

NANJING DELOVA BIOTECH CO., LTD.

Attorney

Yue (Robert) Xu

First Use Date

Oct 15, 2025

Filing Date

Feb 27, 2025

Add to watchlist:

No watchlists yet
View on USPTO

QAMZOVA Trademark

Serial Number: 99060475

QAMZOVA is a trademark filed by NANJING DELOVA BIOTECH CO., LTD. on February 27, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

NANJING DELOVA BIOTECH CO., LTD. (4 trademarks)

Room 509, 510, Bldg 3, No. 99 Lize Road
Nanjing, Jiangsu, 211112 , CN

Entity Type: 99

Trademark Details

Filing Date

February 27, 2025

Registration Date

Not Registered

First Use Anywhere

October 15, 2025

First Use in Commerce

October 15, 2025

Published for Opposition

September 9, 2025

Goods & Services

Medicines made of Chinese traditional medicinal herbs; Medicines for human purposes in the nature of pain relief medications; Medicines for human purposes for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of infectious diseases, pain, cancer and tumors; Drugs for medical purposes for the treatment of pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; Pre-filled syringes for medical purposes sold filled with pharmaceutical preparations for skin care, skin regeneration, skin moisturization, and aesthetic skin treatments to treat skin disorders; Pre-filled syringes for medical purposes sold filled with hyaluronic acid and Botulinum toxin; Pre-filled syringes for medical purposes sold filled with pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports related injuries, cerebral palsy, muscle spasms, tremors and pain; Pre-filled syringes for medical purposes sold filled with pharmaceutical preparations for the treatment of viral diseases, pharmaceutical preparations for blood infusions, pharmaceutical preparations, specifically, dantrolene sodium for injections, and emergency pharmaceutical preparations containing diluents and active pharmaceutical ingredients for the treatment of wounds; Analgesics; Biochemical medicines for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Chemical preparations for pharmaceutical purposes for the prevention and treatment of cardiovascular and cerebrovascular diseases, kidney diseases, liver diseases, bone diseases, hypercalcemia, inflammation, pain, diseases and disorders of the immune system, digestive system, metabolic system, nervous system; Dietetic foods adapted for medical purposes; Medicines for veterinary purposes for the treatment of infectious diseases, viral conditions, skin conditions, pain, and inflammation; First aid kits; First-aid boxes, filled

Filing History

STATEMENT OF USE PROCESSING COMPLETE
Jun 23, 2026 SUPC
USE AMENDMENT FILED
Mar 20, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 20, 2026 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 4, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 3, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 5, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 4, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 4, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 4, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 10, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jun 10, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jun 10, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 2, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 27, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 27, 2025 NWOS
NEW APPLICATION ENTERED
Feb 27, 2025 NWAP